Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.

Espinel, Eugenia

Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study. [electronic resource] - BMC research notes Aug 2013 - 306 p. digital

Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1756-0500

10.1186/1756-0500-6-306 doi


Aged
Angiotensin Receptor Antagonists--therapeutic use
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Double-Blind Method
Female
Humans
Hyperkalemia--etiology
Kidney Failure, Chronic--complications
Male
Middle Aged